At Angels for Change, we believe that ending drug shortages requires more than urgency, it requires alignment, collaboration, and bold action across every part of the healthcare ecosystem.
That’s why we’re extremely proud to be recognized by the U.S. Pharmacopeia Convention as a voting member among a diverse network of more than 450 organizations working together to strengthen trust in medicines and improve global health outcomes.
Laura Bray presents the 2025 Drug Shortage Guardian Awards at USP.
The USP Convention brings together leaders from across healthcare, science, patient advocacy, academia, government, and industry—each contributing expertise to shape the standards that help improve health through public standards worldwide.
This growing and evolving membership reflects a shared understanding: resilient supply chains and high-quality medicines don’t happen in isolation. They are built through collective responsibility, shared data, and coordinated action.
For Angels for Change, this mission aligns deeply with our own work.
Every day, patients across the United States face treatment delays, substitutions, or interruptions due to preventable drug shortages. Through initiatives like Project PROTECT and our national Drug Shortage Hotline, we’ve seen firsthand that solutions exist when stakeholders come together early, transparently, and with patient impact at the center.
USP’s Convention model reinforces this same principle—bringing together over 450 organizations to guide standards, strengthen systems, and elevate the science behind medicine quality.
Laura Bray and Vimala Raghavendran, Angels for Change's 2025 Change Maker of the Year.
As new members join this community, the opportunity grows stronger: to connect standards with real-world access challenges, to bridge policy with patient experience, and to ensure that quality and availability move forward together—not separately.
At Angels for Change, we are encouraged by this continued expansion of collaborative leadership. Ending drug shortages will require all of us to move in alignment toward a shared goal of reliable access to life-saving medicines for every patient, every time.
We look forward to continued partnership across the USP Convention community and beyond as we work to end drug shortages once and for all.
““The addition of these Members reflects stronger engagement across regions and sectors in advancing quality, supporting a resilient medicines supply chain, and protecting people’s health.””
Convention Member additions
The following organizations have joined the USP Convention as of Spring 2026:
African Medicines Agency (AMA)
Agence Béninoise du Médicament et des autres Produits de Santé (ABRP)
Algeria National Agency for Pharmaceutical Products (ANPP)
Angels for Change
Canadian Generic Pharmaceutical Association (CGPA)
Duke-Margolis Center for Health Policy
Egyptian Drug Authority (EDA)
Indonesian Food and Drug Authority (BPOM)
Institute of Drug Quality Control – Ho Chi Minh City
International Pharmaceutical Students’ Federation (IPSF)
Medicines Control Authority of Zimbabwe (MCAZ)
Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMGMAN)
Rwanda Food and Drugs Authority (Rwanda FDA)
Union des Opérateurs Pharmaceutiques (UNOP)
About the USP Convention
The USP Convention is one of USP’s governing bodies, providing input and insights that strengthen USP’s work and impact around the world. Convention membership represents a broad cross-section of the global health ecosystem and includes 450+ member organizations from more than 50 countries, representing expert perspectives of science, manufacturing, regulatory, patient advocacy, government, and academia.
Through the USP Convention, Members elect the Board of Trustees and Council of Experts – USP's other two governing bodies – supporting USP’s mission to protect and promote health by advancing quality across the lifecycle of medicines worldwide.
For additional information, please contact: mediarelations@usp.org
About USP
USP is a private, non‑profit scientific organization that collaborates with stakeholders around the world to develop public quality standards and solutions that support quality across the development, manufacturing, and delivery of regulated health products; strengthen regulatory systems; enhance supply reliability; and support the adoption of innovation. Used in more than 150 countries, USP standards and solutions play a critical role in increasing the availability of quality medicines, dietary supplements, and food ingredients worldwide.
